Rajesh C. Shrotriya

2014

In 2014, Rajesh C. Shrotriya earned a total compensation of $4.1M as Chairman and Chief Executive Officer at Spectrum Pharmaceuticals, a 27% decrease compared to previous year.

Compensation breakdown

Bonus$900,000
Option Awards$2,011,423
Salary$900,000
Other$294,140
Total$4,105,563

Shrotriya received $2M in option awards, accounting for 49% of the total pay in 2014.

Shrotriya also received $900K in bonus, $900K in salary and $294.1K in other compensation.

Rankings

In 2014, Rajesh C. Shrotriya's compensation ranked 2,059th out of 13,032 executives tracked by ExecPay. In other words, Shrotriya earned more than 84.2% of executives.

ClassificationRankingPercentile
All
2,059
out of 13,032
84th
Division
Manufacturing
726
out of 4,966
85th
Major group
Chemicals And Allied Products
226
out of 1,686
87th
Industry group
Drugs
173
out of 1,365
87th
Industry
Pharmaceutical Preparations
144
out of 1,043
86th
Source: SEC filing on April 17, 2017.

Shrotriya's colleagues

We found four more compensation records of executives who worked with Rajesh C. Shrotriya at Spectrum Pharmaceuticals in 2014.

2014

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Operating Officer

2014

Kurt Gustafson

Spectrum Pharmaceuticals

Chief Financial Officer

2014

Lee Allen

Spectrum Pharmaceuticals

Chief Medical Officer

2014

Joseph Keller

Spectrum Pharmaceuticals

Chief Operating Officer

You may also like